TSHR and Graves ophthalmopathy: The effect of stimulatory anti-TSHR antibodies is an increase in thyroid hormone production leading to autoimmune hyperthyroidism (Graves’ disease) as well as Graves’ ophthalmopathy, and more than half of the patients with Graves’ disease are positive for such antibodies [370,371].